Carboplatin and Respiratory rate increased - a phase IV clinical study of FDA data

Summary:

Respiratory rate increased is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Taxol, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Respiratory rate increased when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Respiratory rate increased?

Respiratory rate increased (excess breathing rate/min) is found to be associated with 883 drugs and 1,059 conditions by eHealthMe. Check the latest studies of Respiratory rate increased.

On Jul, 11, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 88 people (0.07%) have Respiratory rate increased.

Could Carboplatin cause Respiratory rate increased?

Among these 88 people:

How long have people been on Carboplatin when they have Respiratory rate increased? *

What is the gender of people who have Respiratory rate increased when taking Carboplatin? *

female: 61.36 %
male: 38.64 %

What is the age of people who have Respiratory rate increased when taking Carboplatin? *

What are other drugs people take besides Carboplatin? *

What are other side effects people have besides Respiratory rate increased? *

Heart Rate Increased: 31 people, 35.23%
Hypotension (abnormally low blood pressure): 25 people, 28.41%
Dyspnea (difficult or laboured breathing): 22 people, 25.00%
Fever: 20 people, 22.73%
Haemoglobin Decreased: 18 people, 20.45%
Oxygen Saturation Decreased: 18 people, 20.45%
Nausea (feeling of having an urge to vomit): 17 people, 19.32%
Chest Pain: 16 people, 18.18%
Fatigue (feeling of tiredness): 16 people, 18.18%
Haematocrit Decreased: 16 people, 18.18%

What are the existing conditions these people have? *

Tumor: 3 people, 3.41%
Ovarian Cancer Metastatic (cancer of ovary spreads to other organ or parts): 3 people, 3.41%
Ovarian Cancer (cancer of ovary): 3 people, 3.41%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 2.27%
Fallopian Tube Cancer (cancer of fallopian tube): 2 people, 2.27%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 2.27%
Lung Cancer Metastatic (lung cancer spreads to other parts): 2 people, 2.27%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 2 people, 2.27%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 2 people, 2.27%
Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 2 people, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Respiratory rate increased?

- Check whether Respiratory rate increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory rate increased:

Respiratory rate increased (883 drugs)

Browse all the conditions that are associated with Respiratory rate increased:

Respiratory rate increased (1,059 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.